Dr. Mes-Masson obtained her Ph.D. from the Department of Microbiology and Immunology at McGill University in 1984. From 1984-1986, she completed post-doctoral studies at the Molecular Biology Institute, University of California Los Angeles. After a short period as a research associate at the Biotechnology Research Institute, Dr Mes-Masson joined the Institut du cancer de Montréal and the Department of Medicine at the Université de Montréal in 1989. A full professor since 2001, Dr. Mes-Masson was the Scientific Director of the Institut du cancer de Montréal and Director of cancer research at the Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM) from 2003-2018 and in 2017 accepted the position of Associate Director, Basic and Translational Research, at the CRCHUM. While maintaining an active basic research program that focuses on the molecular events that contribute to cancer initiation and progression, her laboratory has pioneered the development of novel cell- and tissue-based models for ovarian cancer. More recently Dr. Mes-Masson pursues research largely focused on delivering personalized medicine and her research focuses on the prediction of therapeutic responses and the development of new therapeutic agents for ovarian cancer.